Skip to main content

Table 2 Most frequently occurring adverse events (AE) in the safety population (incidence ≥ 3.0%)

From: Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease

Preferred term

Percent of patients

 

N = 902

Patients with at least 1 AE

74.7

Weight decreased

11.2

Fall

8.8

Agitation

6.8

Urinary tract infection

5.9

Aggression

5.8

Diarrhea

4.3

Nausea

3.5

Hypertension

3.1

Syncope

3.1

Depression

3.0

Weight increased

3.0